Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M81.6Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M8.2EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)25.9Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.1PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,100,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XTL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

XTL is held by these investors:



XTL: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about XTL:

    News about XTL:

    Articles On GuruFocus.com
    More Rate Hikes Good for the Market? Feb 20 2017 
    What Does Seth Klarman Like About ViaSat? Feb 20 2017 
    This Guru Loves Valeant; Should You? Feb 20 2017 
    Leith Wheeler Fall Quiet Counsel: Inflation Mandate Renewal Feb 20 2017 
    Spiros Segalas' Harbor Capital Appreciation Fund 4th Quarter Commentary Feb 20 2017 
    Kraft Heinz Is Value Stock Picking With Unilever Feb 20 2017 
    ExxonMobil: A Great Buying Opportunity Feb 20 2017 
    HollyFrontier Declares Quarterly Dividend Feb 20 2017 
    Gold Fields Releases 2016 Financial Results Feb 20 2017 
    GM, Ford Witness China Sales Decline in January Feb 20 2017 

    More From Other Websites
    XTL Biopharmaceuticals Expands Clinical Advisory Board to Support Phase II Study of HCDR1 in... Feb 13 2017
    Telecom ETFs: What Lies Ahead in 2017? Feb 07 2017
    ETFs That Sound Alike Are Often Different Jan 26 2017
    XTL Biopharmaceuticals Announces Ratio Change of its Depositary Receipt Program Jan 25 2017
    XTL Biopharmaceuticals to Present at Biotech Showcase Dec 19 2016
    Dow closes in on 20K mark Dec 13 2016
    XTL Biopharmaceuticals Receives NASDAQ Notification Regarding Minimum Bid Requirements Nov 09 2016
    Fed Holds Off Rate Hike for Now: Top 5 Gainers Sep 22 2016
    After Friday's Swoon, Should You Run for the Exits? Sep 11 2016
    XTL Biopharmaceuticals Announces the European Patent Office has Issued a Patent for its Lupus Drug... Sep 07 2016
    XTL Biopharmaceuticals to Present at Rodman & Renshaw Conference on September 12, 2016 Sep 06 2016
    Top ETFs In Neglected Telecom Sector Sep 01 2016
    XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1 Aug 11 2016
    Dow ETF Treads Water As Key Blue Chips Post Results That Lack Salt Jul 26 2016
    Thursday links: a tightrope walk May 26 2016
    XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 May 16 2016
    New highs for the market? May 09 2016
    Where to Invest if the Fed Stays Dovish (XLU,XTL) Apr 14 2016
    Triple digit gains in Dow Apr 12 2016
    XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of... Mar 21 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)